Not Rated
Fund Size
(1.65% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 22-Sep-25 | 9618.80 | -3.81% | - | -2.65% | 204/226 |
1 Month | 29-Aug-25 | 9804.50 | -1.96% | - | 1.31% | 221/225 |
3 Month | 27-Jun-25 | 9633.00 | -3.67% | - | -1.11% | 159/217 |
6 Month | 28-Mar-25 | 10388.40 | 3.88% | - | 9.64% | 194/212 |
YTD | 01-Jan-25 | 9465.90 | -5.34% | - | 1.69% | 169/200 |
1 Year | 27-Sep-24 | 9584.30 | -4.16% | -4.14% | -4.36% | 72/181 |
2 Year | 29-Sep-23 | 14380.30 | 43.80% | 19.89% | 19.12% | 58/139 |
3 Year | 29-Sep-22 | 18263.70 | 82.64% | 22.21% | 21.02% | 41/115 |
5 Year | 29-Sep-20 | 23205.00 | 132.05% | 18.32% | 23.66% | 73/90 |
10 Year | 29-Sep-15 | 35794.70 | 257.95% | 13.59% | 15.31% | 46/65 |
Since Inception | 02-Jan-13 | 79495.60 | 694.96% | 17.66% | 12.59% | 52/180 |
Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 27-Sep-24 | 12000 | 11951.82 | -0.4 % | -0.74 % |
2 Year | 29-Sep-23 | 24000 | 26567.03 | 10.7 % | 10.08 % |
3 Year | 29-Sep-22 | 36000 | 47465.92 | 31.85 % | 18.77 % |
5 Year | 29-Sep-20 | 60000 | 92964.91 | 54.94 % | 17.53 % |
10 Year | 29-Sep-15 | 120000 | 314141.07 | 161.78 % | 18.29 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 9975.8 | 11.94% | -0.28% | 14.41% (Sep 2024) | 11.94% (Aug 2025) | 62.56 L | 0.00 |
Divis Laboratories Ltd. | Pharmaceuticals | 6131.7 | 7.34% | -0.21% | 9.65% (Nov 2024) | 7.34% (Aug 2025) | 10.00 L | 0.00 |
Cipla Ltd. | Pharmaceuticals | 5086.1 | 6.09% | 0.40% | 6.09% (Aug 2025) | 5.32% (Dec 2024) | 32.00 L | 0.00 |
Lupin Ltd. | Pharmaceuticals | 5085.9 | 6.09% | 0.16% | 8.47% (Dec 2024) | 5.82% (May 2025) | 26.84 L | 0.00 |
Apollo Hospitals Enterprises Ltd. | Hospital | 4937.3 | 5.91% | 0.34% | 5.91% (Aug 2025) | 5.13% (Nov 2024) | 6.49 L | 0.00 |
Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 4934.7 | 5.90% | 0.21% | 5.9% (Aug 2025) | 5.1% (Nov 2024) | 39.16 L | 0.00 |
Medplus Health Services Ltd. | Pharmacy retail | 3054 | 3.65% | -0.21% | 4.2% (May 2025) | 2.35% (Sep 2024) | 36.27 L | 0.00 |
Vijaya Diagnostic Centre Ltd. | Healthcare service provider | 2909.2 | 3.48% | -0.07% | 4.09% (Nov 2024) | 3.24% (May 2025) | 28.87 L | 0.00 |
GlaxoSmithKline Pharmaceuticals Ltd. | Pharmaceuticals | 2543.3 | 3.04% | -0.27% | 3.73% (May 2025) | 2.02% (Jan 2025) | 9.13 L | 0.00 |
Gland Pharma Ltd. | Pharmaceuticals | 2471.4 | 2.96% | -0.16% | 3.27% (Jun 2025) | 2.59% (Apr 2025) | 13.21 L | 0.00 |
Name | Type of Instrument | Weight (%) |
---|---|---|
TREPS | TREPS | 0.41% |
Net Receivables | Net Receivables | 0.13% |
Margin | Margin | 0.00% |
Ratios calculated on daily returns for last 3 years (Updated as on 29th August, 2025)
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
Nippon India Taiwan Equity Fund - Direct Plan - Growth | NA | 389.09 | 2.73 | 21.87 | 59.31 | 39.55 | 38.56 |
Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth | NA | 249.75 | 1.49 | 9.91 | 20.73 | 24.07 | 19.71 |
Nippon India US Equity Opportunities Fund - Direct Plan - Growth | NA | 713.51 | 1.60 | 4.90 | 13.04 | 15.80 | 23.22 |
Franklin Asian Equity Fund - Direct - Growth | NA | 259.99 | 5.69 | 8.70 | 18.34 | 11.58 | 15.34 |
Nippon India Japan Equity Fund - Direct Plan - Growth | NA | 283.56 | 1.70 | 8.17 | 16.48 | 11.08 | 19.95 |
HDFC Defence Fund - Direct Plan - Growth | NA | 6532.01 | 4.95 | -7.10 | 20.43 | 9.43 | 0.00 |
Motilal Oswal Business Cycle Fund - Direct Plan - Growth | NA | 1976.19 | -3.03 | -1.04 | 6.19 | 8.44 | 0.00 |
SBI Banking & Financial Services Fund - Direct Plan - Growth | NA | 8370.76 | 2.62 | -2.05 | 10.07 | 8.38 | 21.19 |
DSP Banking & Financial Services Fund - Direct Plan - Growth | NA | 1331.23 | 4.20 | -2.61 | 8.66 | 6.65 | 0.00 |
Motilal Oswal Manufacturing Fund - Direct Plan - Growth | NA | 786.43 | 2.76 | 2.28 | 16.48 | 6.26 | 0.00 |
Out of 84 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 6 is/are ranked 4 * , 12 is/are ranked 3 * , 8 is/are ranked 2 * , 1 is/are ranked 1 * , and 56 schemes are not ranked. See more about AMC
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
Nippon India Small Cap Fund - Direct Plan - Growth | 4 | 64821.04 | 0.05 | -2.68 | 11.68 | -7.89 | 24.34 |
Nippon India Multicap Fund - Direct Plan - Growth | 4 | 46215.71 | -0.53 | -1.36 | 11.28 | -3.07 | 23.75 |
Nippon India Large Cap Fund - Direct Plan - Growth | 5 | 45012.18 | -0.03 | -0.82 | 9.34 | -1.32 | 21.26 |
Nippon India Growth Mid Cap Fund - Direct Plan - Growth | 3 | 38385.96 | -0.81 | -2.48 | 11.32 | -3.48 | 25.70 |
Nippon India Liquid Fund - Direct Plan - Growth | 2 | 30964.83 | 0.46 | 1.44 | 3.26 | 6.92 | 7.11 |
Nippon India Money Market Fund - Direct Plan - Growth | 2 | 23880.58 | 0.47 | 1.54 | 3.98 | 7.95 | 7.70 |
Nippon India Arbitrage Fund - Direct Plan - Growth | 3 | 15505.59 | 0.45 | 1.50 | 3.41 | 7.18 | 7.63 |
Nippon India ELSS Tax Saver Fund - Direct Plan - Growth | 2 | 14934.46 | -0.29 | -1.92 | 8.56 | -6.25 | 19.07 |
Nippon India Ultra Short Duration Fund - Direct Plan - Growth | 1 | 11075.99 | 0.51 | 1.63 | 3.87 | 7.88 | 7.72 |
Nippon India Low Duration Fund - Direct Plan - Growth | 2 | 10048.47 | 0.56 | 1.61 | 4.16 | 8.20 | 7.77 |